Showing results (1-10 of 53) with videos related to
Sort By:
Pageof 6
Biologics : Targets & Therapy|March 27, 2014
Targeted therapy for sarcomasCharles Forscher, Monica Mita, Robert FiglinExpert Opinion on Investigational Drugs|August 29, 2017
Aldoxorubicin for the treatment of soft tissue sarcomaEsha Sachdev, Divesh Sachdev, Monica MitaCurrent Oncology Reports|June 6, 2015
Adnectin-targeted inhibitors: rationale and resultsEsha Sachdev, Jun Gong, Bobbie Rimel, et al.Current Drug Targets|July 23, 2011
Vascular disrupting agents (VDA) in oncology: advancing towards new therapeutic paradigms in the clinicMatthew A Spear, Patricia LoRusso, Alain Mita, et al.Targeted Oncology|May 3, 2011
The emerging role of mammalian target of rapamycin inhibitors in the treatment of sarcomasSushma Vemulapalli, Alain Mita, Yesid Alvarado, et al.Targeted Oncology|June 28, 2017
Targeting the Wnt Pathway in Cancer: A Review of Novel TherapeuticsRoya Tabatabai, Yuliya Linhares, David Bolos, et al.Expert Opinion on Investigational Drugs|November 18, 2008
Deforolimus (AP23573) a novel mTOR inhibitor in clinical developmentMonica Mita, Kamalesh Sankhala, Issam Abdel-Karim, et al.Targeted Oncology|April 22, 2009
The emerging safety profile of mTOR inhibitors, a novel class of anticancer agentsKamalesh Sankhala, Alain Mita, Kevin Kelly, et al.Targeted Oncology|February 12, 2016
The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical developmentJun Gong, Gauri Kelekar, James Shen, et al.Expert Opinion on Biological Therapy|June 17, 2009
Reovirus-based therapy for cancerKevin Kelly, Steffan Nawrocki, Alain Mita, et al.Pageof 6